共 11 条
[1]
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial[J] . Gilles Montalescot,Stephen D Wiviott,Eugene Braunwald,Sabina A Murphy,C Michael Gibson,Carolyn H McCabe,Elliott M Antman.The Lancet . 2009 (9665)
[2]
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome[J] . Robert P. Giugliano,Eugene Braunwald.Journal of the American College of Cardiology . 2009 (16)
[6]
Drug-Eluting Stents: Dual Antiplatelet Therapy for Every Survivor?[J] . Anthony A. Bavry,Deepak L. Bhatt.Circulation . 2007 (7)
[7]
A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation[J] . John T. Brandt,Christopher D. Payne,Stephen D. Wiviott,Govinda Weerakkody,Nagy A. Farid,David S. Small,Joseph A. Jakubowski,Hideo Naganuma,Kenneth J. Winters.American Heart Journal . 2007 (1)
[10]
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)[J] . Sidney C. Smith,Ted E. Feldman,John W. Hirshfeld,Alice K. Jacobs,Morton J. Kern,Spencer B. King,Douglass A. Morrison,William W. O’Neill,Hartzell V. Schaff,Patrick L. Whitlow,David O. Williams,Elliott M. Antman,